Hard drug use in Norway

NAD Nordic Studies on Alcohol and Drugs

Volumn 27, Issue 1, 2010, Pages 87-94

  Amundsen, Ellen J ^a   Bretteville Jensen, Anne Line ^a  

^a Institute for Alcohol and Drug Research   (Norway)

Author keywords

Estimation; Intravenous drug user IDU; Mortality multiplier method; Prevalence; Substance use

Indexed keywords

EID: 77953048034     PISSN: 14550725     EISSN: 14586126     Source Type: Journal    
DOI: 10.1177/145507251002700106     Document Type: Review

References (15)

1. Bretteville-Jensen, A. L. (2005): Økonomiske aspekter ved sprØytemisbrukernes forbruk av rusmidler. En analyse av intervjuer foretatt 1993-2004. (Economic aspects of substance consumption among IDU. An analysis of data from 1993 to 2004). Report No. 4, Oslo: SIRUS/Norwegian Institute for Alcohol and Drug Research
2. Bretteville-Jensen, A. L. & Amundsen, E. J. (2006): Omfang av sprØytebruk i Norge (Extent of injecting drug use in Norway). Report No. 5, Oslo: SIRUS/ Norwegian Institute for Alcohol and Drug Research
3. Bretteville-Jensen, A. L. & Ødegård, E. (1999): Injeksjonsmisbrukere i Norge (Injecting drug users in Norway). Report No. 4, Oslo: SIFA (SIRUS/Norwegian Institute of Alcohol and Drug Research)
4. Clausen, T. & Anchersen, K. & Waal, H. (2008): Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence 94 (1-3): 151-157
5. Darke, S. & Degenhardt, L. & Mattick, R. (2007): Mortality amongst Illicit Drug Users, Epidemiolgy, Causes and Interventions. Cambridge: Cambridge University Press
6. EMCDDA (2009): Problem drug use (PDU) Retrieved 23.09. 2009, from http://www.emcdda.europa.eu/themes/key-indicators/pdu
7. Hay, G. & McKeganey, N. & Wiessing, L. & Hartnoll, R. (1999): Methodological Guidelines to Estimate the Prevalence of Problem Drug Use on the Local Level. Lisbon: EMCDDA
8. Iversen, E. & Lauritzen, G. & Skretting, A. & Skutle, A. (2008): Det nasjonale dokumentasjonssystemet innen tiltaksapparatet for rusmiddelbrukere: Klientkartleggingsdata. Rapport for 2007. (The National Client Documentation System of treatment and care for drug users. Report for 2007) Bergen: Stiftelsen Bergensklinikkene/Statens institutt for rusmiddelforskning
9. Kraus, L. & Kümmler, P. & Augustin, R. & Pfeiffer, T. & Simon, R. & Wiessing, L. & Hartnoll, R. et al. (2004): Key Epidemiological Indicator: Prevalence of problem drug use. Lisbon: EMCDDA
10. Melberg, H. O. & Lauritzen, G. & Ravndal, E. (2003): Hvilken nytte, for hvem og til hvilken kostnad?: en prospektiv studie av stoffmisbrukere i behandling. (Which benefit, for whom and at what cost?: a prospective study of drug users in treatment). Oslo: SIRUS/Norwegian Institute for Alcohol and Drug Research
11. Skog, O.-J. (1990): Utviklingen av intravenØst narkotikamisbruk i Norge: anslag for insidens og prevalens. (The Developement of Intravenous Drug Use in Norway: estimate of incidence and prevalence). Report No. 1, Oslo: SIFA (SIRUS/Norwegian Institute for Alcohol and Drug Research)
12. Statistical Bulletin 2009 (2009): Statistical Bulletin. Retrieved 25.09. 2009 from http://www.emcdda.europa.eu/stats09
13. Waal, H. & Clausen, T. & Håseth, A. & Lillevold, P. A. (2008): LAR i Norge. Statusrapport 2007 (Medically Assisted Treatment in Norway. Report on Status 2007). Oslo: SERAF/ Norwegian Centre for Addiction Research
14. Ødegård, E. & Amundsen, E. J. & Kielland, K. B. (2007): Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers -A competing risk approach. Drug and Alcohol Dependence 89 (2-3): 176-182
15. Ødegård, E. (2008): Narkotika- og alkoholproblemer blant innsatte i norske fengsler (Substance use problems among inmates in Norwegian prisons) Nordisk alkohol- & narkotikatidsskrift 25 (3): 169-185.